NEO Stock Analysis: Buy, Sell, or Hold?
NEO - NeoGenomics, Inc.
$12.06
-0.34 (-2.74%)
▼
HOLD
LOW Confidence
Last Updated: January 30, 2026
Earnings: Feb 17, 2026
15d
Get Alerted When NEO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NEO shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: NEO shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
In-depth Analysis How we analyze
Valuation Analysis: NEO is currently trading at $12.06, which is considered fair relative to its 30-day fair value range of $12.17 to $12.90. The stock's valuation (Forward PE: 65.3) is in line with its historical norms (67.1). Remarkably, the market is currently pricing in an annual earnings decline of 0.9% over the next few years. This pessimistic expectation contrasts with the company's recent 130.6% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, NEO is in a strong uptrend. The price is currently testing key support at $11.81. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $14.43 (+19.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NEO is in a strong uptrend. The price is currently testing key support at $11.81. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $14.43 (+19.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$12.17 -
$12.90
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
70.0%
Protect Your Profits
Holding NEO? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($14.43)
- CAUTION: Recommendation downgraded due to -5.9% 5-day decline
Fair Price Analysis
30-Day Fair Range
$12.17 -
$12.90
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$11.81
Resistance Level
$13.29
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
65.33
Wall Street Target
$14.43
(+19.6%)
Revenue Growth (YoY)
11.9%
Earnings Growth (YoY)
130.6%
Profit Margin
-16.0%
Valuation Discount vs History
-0.9% cheaper
PE vs Historical
65.3 vs 67.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.9%
(market-implied from PE analysis)
1-Year Target
$11.95
(-1%)
2-Year Target
$11.84
(-2%)
3-Year Target
$11.74
(-3%)
3-Yr Target (if PE normalizes)
(PE: 65→67)
$12.06
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 65.3, Growth: 92.3%)
$40.70
(+238%)
Base:
(SPY PE: 22.3, Growth: 92.3%)
$13.89
(+15%)
Bear:
(PE: 19.0, Growth: 92.3%)
$11.81
(-2%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 65.3 to 67.1
Stabilization Target:
$12.39
(+2.7%)
PE Expansion Potential:
+2.7%
Last updated: February 01, 2026 6:05 AM ET
Data refreshes hourly during market hours. Next update: 7:05 AM
Data refreshes hourly during market hours. Next update: 7:05 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NEO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$653 | 47 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 57 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$121 | 62 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$263 | 47 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$257 | 58 HOLD |
Advanced NEO Option Strategies
Professional options setups generated by AI based on today's NEO price and gamma walls.
